What's new? Clinical progression and staging of Parkinson's disease

摘要: Several new advances facilitate current understanding of the progression Parkinson’s disease. The application statistical modeling techniques has helped to estimate rates clinical decline in context symptomatic interventions. These approaches may allow a means for testing neuroprotection effects even when patients are on dopaminergic treatment. Further, development rating scales, specifically Movement Disorder Society-initiated revision Unified Disease Rating Scale capitalized greater appreciation non-motor elements Finally, adaptations technologies that computer-based and enable data transmission from at-home environments researchers capture disease impairment disability with potentially precision much more frequently than permissible hospital clinic or practice setting.